Add articles to your saved list and come back to them any time. Over-the-counter medications for heartburn, reflux and morning sickness are at the centre of a class action investigation over ...
After a landmark $US425 million settlement in the United States, the drugs are being investigated in Australia over alleged ...
Carillon Eagle Growth & Income Fund highlighted stocks like AstraZeneca PLC (NASDAQ:AZN) in the second quarter 2024 investor letter. AstraZeneca PLC (NASDAQ:AZN) is a biopharmaceutical company ...
AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that add up to a wide moat. The strong replenishment of new drugs ...
Qiagen and AstraZeneca are expanding their diagnostics partnership, with plans to explore the use of genomic profiling in chronic diseases beyond cancer. The long-time collaborators, which ...
AstraZeneca has beaten all healthcare-focused ETFs. The stock is up by over 27% this year, helped by its oncology business. It has gotten highly overbought, meaning that a pullback is coming ...
Chris Nemeth, 51, worked in airline logistics until he got the AstraZeneca vaccine in July 2021 and developed chronic inflammatory demyelinating polyneuropathy (CIPD) which can cause numbness ...
However, a new concealer is a cause for great excitement and I’ve been testing out the MAC Studio Radiance 24HR Luminous Lift Concealer – a blend of hyaluronic, Vitamin C and Niacinamide so it’s ...
AstraZeneca is spending $135 million to expand a biologics facility in Sweden due to an increase in demand for its pre-filled syringe drug products, a … ...
British pharma giant AstraZeneca plans to spend $135 million to expand the manufacturing operations footprint of its site in Södertälje, Sweden, by 50%. The project calls for a 2,700-square ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback